Status:

RECRUITING

Multigen Plus CCK and AMF TT Cones Follow Up Study

Lead Sponsor:

Limacorporate S.p.a

Conditions:

Total Knee Arthroplasty

Revision Total Knee Arthroplasty

Eligibility:

All Genders

18+ years

Brief Summary

This study is aimed to provide a clinical and radiographic evaluation of 68 condylar-constrained Total Knee Arthroplasty (TKA) using a single type of prosthesis (Multigen Plus CCK configuration), alon...

Detailed Description

This is a post-market, multicentric, prospective, open label study. It is a post-marketing clinical study because the investigational devices are registered, CE marked, and used according to the inten...

Eligibility Criteria

Inclusion

  • Male or female.
  • Age ≥ 18 years old.
  • Given written informed consent approved by the reference Ethics Committee (EC).
  • Subjects in whom a decision has already been made to perform a Total Knee Arthroplasty with Multigen Plus system as per Indication For Use. The decision to implant a Multigen Plus CCK system, alone or involving the AMF TT cones, must be taken prior to, and independently from, the decision to enrol the subject. This decision should be made in accordance with routine clinical practice at the study site concerned.
  • Subjects able to comply with the Study Protocol.

Exclusion

  • Age \< 18 years old.
  • Subjects with any Multigen Plus system contraindication for use, or any AMF TT cones contraindication for use when used in combination with the Multigen Plus CCK, as reported in the current Instruction For Use.
  • Any clinically significant pathology based on the medical history that the Investigator feels may affect the study evaluation.
  • Female subjects who are pregnant, nursing, or planning a pregnancy.
  • Previous knee replacement on the contralateral side within the last year and whose outcome is achieving an KSS \< 70 points.

Key Trial Info

Start Date :

June 21 2022

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

July 1 2026

Estimated Enrollment :

68 Patients enrolled

Trial Details

Trial ID

NCT05314491

Start Date

June 21 2022

End Date

July 1 2026

Last Update

March 10 2025

Active Locations (3)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (3 locations)

1

Hospital Senhora da Oliveira in Guimarães

Guimarães, Portugal

2

Saints Cyril and Methodius Hospital

Bratislava, Slovakia

3

Royal Devon and Exeter Hospital

Exeter, United Kingdom